DILI clinical patterns and aetiological investigations
Drug-Induced Liver Injuries
Causality of DILI
Specifically DILI during clinical trials and in post-marketing
Who should Attend
Healthcare professionals involved in the monitoring and assessment of Drug-Induced Liver Injury occurring in development or after marketing:
People in charge of pharmacovigilance in regulatory authorities and in companies
EU Qualified Persons for Pharmacovigilance
Investigators
Safety assessors in clinical trials and postmarketing
Clinical Research Associates
Past Events
Diagnosis and Management of Drug Induced Liver Injury (DILI) 2016 - 14-15 Jun 2016, Holiday Inn London - Kensington Forum, United Kingdom (56082)
Diagnosis and Management of Drug Induced Liver Injury (DILI) 2026
Important
Please, check "Diagnosis and Management of Drug Induced Liver Injury (DILI)" official website for possible changes, before making any traveling arrangements
Event Categories
Health & Medicine: Gastroenterology, Hepatology, Pharma
